These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6397176)

  • 1. Ocular toxicology update.
    Fraunfelder FT; Meyer SM
    Aust J Ophthalmol; 1984 Nov; 12(4):391-4. PubMed ID: 6397176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim report: National Registry of Possible Drug-Induced Ocular Side Effects.
    Fraunfelder FT
    Ophthalmology; 1979 Jan; 86(1):126-30. PubMed ID: 530559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic reactions to ophthalmic drug preparations.
    Fraunfelder FT; Meyer SM
    Med Toxicol Adverse Drug Exp; 1987; 2(4):287-93. PubMed ID: 3306268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How safe are ocular drugs in pediatrics?
    Palmer EA
    Ophthalmology; 1986 Aug; 93(8):1038-40. PubMed ID: 3763151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new in ocular toxicology?
    Fraunfelder FT
    Sight Sav Rev; 1978; 48(2):53-8. PubMed ID: 715474
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse systemic effects from pledgets of topical ocular phenylephrine 10%.
    Fraunfelder FW; Fraunfelder FT; Jensvold B
    Am J Ophthalmol; 2002 Oct; 134(4):624-5. PubMed ID: 12383833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.
    Shore JH; Fraunfelder FT; Meyer SM
    J Clin Psychopharmacol; 1987 Aug; 7(4):264-7. PubMed ID: 3624510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
    Hutzelmann JE; Polis AB; Michael AJ; Adamsons IA
    Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E; Tipping R; Vogel R
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience.
    Gillies WE; Brooks AM
    Aust N Z J Ophthalmol; 1996 May; 24(2):111-5. PubMed ID: 9199740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic effects of eye drops.
    Adler AG; McElwain GE; Merli GJ; Martin JH
    Arch Intern Med; 1982 Dec; 142(13):2293-4. PubMed ID: 7149872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.